2025. Indacaterol/ Glycopyrronium in Symptomatic Patients with COPD (GOLD 2 and GOLD 3) Versus Salmeterol/ Fluticasone. Indus Journal of Bioscience Research. 3, 4 (Apr. 2025), 614–617. DOI:https://doi.org/10.70749/ijbr.v3i4.859.